Patient info Open main menu

Qvar® 100 Autohaler® – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
100 microgram/dose
Contains active substance:

Patient leaflet - Qvar 100 Autohaler

1. WHAT QVAR® AUTOHALER® IS AND WHAT IT IS USED FOR

Qvar® Autohaler® contains beclometasone dipropionate, which is one of a group of medicines known as corticosteroids.

Qvar® Autohaler® is used to prevent the symptoms of mild, moderate or severe asthma in patients who require regular treatment.

How your medicine works

  • Qvar® Autohaler® works deep in your lungs to make breathing easier by reducing the inflammation, swelling and irritation in the airways. This type of medicine is known as a ‘preventer’. It needs to be taken regularly every day, even if you have no symptoms.
  • This inhaler will not give immediate relief of wheezing or breathlessness during a sudden asthma attack. You will need to use a ‘reliever’ inhaler, which contains a different medicine. You should still continue to use this inhaler.

2. WHAT YOU NEED TO KNOW BEFORE YOU USE QVAR® AUTOHALER®

Do not use Qvar® Autohaler® if you are:

  • allergic (hypersensitive) to beclometasone dipropionate or any of the other ingredients of this medicine (listed in section 6)
  • allergic to other similar inhalers
  • suffering from a sudden attack of breathlessness. It will not help. Use a quick-acting ‘reliever’ inhaler for this purpose and carry it with you at all times.

Warnings and precautions

Talk to your doctor before using Qvar® Autohaler® if:

  • you are suffering from tuberculosis (TB) now or have suffered from it in the past
  • you are allergic to other similar inhalers
  • you must avoid alcohol for any reason

  • your asthma seems to be getting worse. Perhaps you are more wheezy and short of breath than usual, your ‘reliever’ inhaler seems to be less effective, you require more puffs from your ‘reliever’ inhaler than usual, or you do not seem to be getting better. Your doctor may need to increase the dose of your steroid inhaler or give you a course of steroid tablets or change your treatment altogether. If you have had an infection in your chest your doctor may prescribe a course of antibiotics.
  • when transferring from steroid tablets to an inhaler you find that, even if your chest is getting better, you feel generally unwell, you develop a rash, eczema or a runny nose and sneezing (rhinitis). Do not stop treatment with your inhaler unless your doctor tells you to.

Important points to remember while you are using this medicine:

  • Your doctor may prescribe this inhaler to replace steroid tablets, which may mean for a short time you have to take both medicines.

    It is important to follow your doctor’s advice. Whilst you are reducing the number of steroid tablets that you take you may feel generally unwell even though you can breathe as well as normal or better. If you have other allergies, you may find that stopping your steroid tablets makes them worse. If this happens, keep using your inhaler and tell your doctor.

    • If you have been treated for a long time with high doses of inhaled steroid, you may require a course of steroid tablets or possibly a steroid injection in times of stress. For example, during admission to hospital after a serious accident, before an operation, during an acute attack of asthma or if you have a chest infection or other serious illness. Your doctor will decide if you need any extra steroid treatment and will also advise you as to how long you need to take the course of steroid tablets and how you should reduce these as you get better.
    • There may be times when you need to take steroid tablets as well as using your inhaler, for example if you have worsening asthma attacks, you get a chest infection or you need an operation. Your doctor may give you a small supply of steroid tablets to be taken in these situations; if he/she does, you will be given full instructions on how and when to take them. Contact your doctor immediately if you think that you need to take steroid tablets, even if you have your own supply.
    • You should have been given a steroid card with this inhaler; if you have not, please ask your pharmacist for one. Make sure you carry your steroid card with you at all times until your doctor decides that it is no longer necessary.
    • Visit your doctor regularly for a review of your condition.
    • If you have to go into hospital, remember to take all your inhalers and other medicines including those bought without prescription with you.
    • Contact your doctor if you experience blurred vision or other visual disturbances.

Other medicines and Qvar® Autohaler®

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including any medicines obtained without a prescription.

In particular tell your doctor if you are taking:

  • disulfiram
  • metronidazole.

Some medicines may increase the effects of Qvar® Autohaler® and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).

Pregnancy, breast-feeding and fertility

If you are pregnant, planning to become pregnant or are breast-feeding, ask your doctor for advice before taking this medicine.

Driving and using machines

Qvar® Autohaler® is not known to affect your ability to drive or operate machinery.

Information about some of the ingredients of Qvar® Autohaler®:

Qvar® contains a small amount of alcohol. Talk to your doctor if you need to avoid alcohol for any reason.

Qvar® Autohaler® contains ethanol

This medicine contains 4.74 mg of alcohol (ethanol) in each puff. The amount in one puff of this medicine is equivalent to less than 1ml beer or 1 ml wine.

The small amount of alcohol in this medicine will not have any noticeable effects.

3. HOW TO USE QVAR® AUTOHALER®

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. There are two strengths of the Qvar® Autohaler® available and your doctor will have chosen the strength which best suits your condition. This inhaler has a softer feel and a different taste than other inhalers you may have used before. This inhaler is an extra fine aerosol which results in more of each dose being delivered to your lungs. Your doctor may, therefore, prescribe a lower dose of this inhaler than your previously used inhaler.

Even when your doctor has prescribed a lower dose, you may find that the number of puffs you are asked to take from this inhaler is the same as from your previous inhaler; this is because this inhaler may be a lower strength product (which means that each puff of this inhaler contains less beclometasone dipropionate than your old inhaler).

Do not take more puffs than your doctor has told you to. In some circumstances, your doctor may prescribe more than the usual number of puffs. You should check with your doctor or pharmacist if you are not sure. The usual number of puffs to take is:

Qvar® Autohaler® 50 micrograms

Adults (including the elderly) and adolescents over 12 years

  • Mild Asthma

    The starting dose is one puff twice a day. This may be increased up to two puffs twice a day.

  • Moderate Asthma

    The starting dose is two puffs twice a day. This may be increased up to four puffs twice a day.

  • Severe Asthma

    The starting dose is four puffs twice a day. This may be increased up to eight puffs twice a day.

The maximum dose is a total of sixteen puffs a day.

Qvar® Autohaler® 100 micrograms

Adults (including the elderly) and adolescents over 12 years

  • Mild Asthma

    The Qvar® Autohaler® 100 micrograms is not suitable for the starting dose. It is suitable for an increased dose of one puff twice a day.

  • Moderate Asthma

    The starting dose is one puff twice a day. This may be increased to two puffs twice a day.

  • Severe Asthma

    The starting dose is two puffs twice a day. This may be increased up to four puffs twice a day.

The maximum dose is a total of eight puffs a day.

Children aged 5 years and over

The starting dose is one puff of Qvar® Autohaler® 50 micrograms twice a day.

Children with well-controlled asthma on doses of up to 400 micrograms per day of other beclometasone dipropionate inhalers or equivalent may be titrated to a dose of 50-100 micrograms twice daily of Qvar®. Qvar® Autohaler® 100 micrograms would not normally be recommended in this age group. However, during periods of deterioration in asthma control, the dose may be increased to 200 micrograms per day in two divided doses. The dose should be reduced to the minimum needed to maintain effective control of asthma.

What to do if you think your treatment is not working

If you think your usual treatment is not working, for example your symptoms are not getting better, or are getting worse, or you need to use more puffs from your reliever inhaler, or if your reliever inhaler does not seem to be working as well as usual, or your peak flow falls, please tell your doctor. Your asthma may be getting worse.

If you use more Qvar® Autohaler® than you should

It is important that you take your dose as stated on the pharmacist’s label, or as advised by your doctor. You should not increase or decrease your dose without seeking medical advice.

If you accidentally take more puffs than recommended, please tell your doctor.

If you forget to use Qvar® Autohaler®

If you forget to use this inhaler at your usual time, take your recommended number of puffs as soon as you remember unless it is nearly time to use your inhaler again. DO NOT take a double dose to make up for a forgotten dose. Then continue to use your inhaler regularly at the correct time, as prescribed by your doctor.

If you stop using Qvar® Autohaler®

This inhaler must be used regularly, even when you feel well. You must not stop using your inhaler unless your doctor tells you to. Ask your doctor for a prescription for a replacement inhaler before this one is empty.

If your doctor decides to stop treatment, return the inhaler to your doctor or pharmacist for safe disposal.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Using Qvar® Autohaler®

Before using your inhaler, please read this leaflet carefully and follow the instructions. If you are not sure how to use the inhaler device, ask your doctor or a pharmacist.

Before use

If this is a new device or if you have not used it for 2 weeks or more, it must be tested before use by releasing two puffs into the air in the following way:

  1. 1. Take the cover off from the mouthpiece, by pulling down on the lip at the back (fig. 1).
  2. 2. Point the mouthpiece away from you so that the puffs of medicine will go into the air. Push the lever up so that it stays up (fig. 2).
  3. 3. Then, to release a puff, push the dose release slide on the bottom of the device in the direction indicated by the arrow on it (fig. 3).
  4. 4. To release the second puff you need to return the lever to its down position (fig. 4) and follow steps 2 and 3 again. After releasing the second puff, return the lever to its down position, to be ready to take a puff of your medicine.

How to use your Qvar® Autohaler® device

Do not use the dose release slide to take your medicine; the Autohaler® device will automatically release a dose when you begin to breathe in from the mouthpiece.

The instructions for taking a puff are given below.

  1. 1. Take the cover off from the mouthpiece, by pulling down on the lip at the back.
  2. 2. Hold your Autohaler® device upright as shown. Push the lever up so that it stays up. Continue to hold your device upright, making sure that your hand is not blocking the air vent (marked by X in fig. 2) at the bottom of the device.
  3. 3. Breathe out as far as is comfortable (fig. 3), then immediately place the mouthpiece in your mouth, and close your lips around it.
  4. 4. Breathe in slowly and deeply through the mouthpiece. Do not stop breathing in when you hear the slight click and feel the puff in your mouth as it is important that you carry on breathing in after the puff is released (fig. 4).
  5. 5. Hold your breath for 10 seconds and then breathe out slowly (fig. 5).
  6. 6. The lever must be lowered to the down position after each puff. If your doctor has prescribed more than one puff, repeat steps 2 - 6. After use, replace the cover on the mouthpiece (fig. 6).

How to tell when the Qvar® Autohaler® is empty

When the device is completely empty you will not feel or hear any propellant being discharged.

Cleaning instructions

For normal hygiene, the mouthpiece of your Autohaler® should be cleaned weekly with a clean, dry tissue or cloth. You should also rinse your mouth with water after using your inhaler.

Caution:

  • Do not wash or put any part of your inhaler in water.
  • Do not push a drying cloth or anything else into any part of the Autohaler® since it may cause damage to its operating parts.
  • Do not take the Autohaler® apart.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If immediately after taking a puff of this inhaler, you feel wheezy or tight-chested do not take any more puffs. Use your reliever inhaler to help your breathing and contact your doctor immediately.

Stop using your inhaler and tell your doctor immediately or go to the casualty department at your nearest hospital if the following happens:

  • an allergic reaction (swelling of the lips, face or neck leading to severe difficulty in breathing; skin rash or hives).

This is a very serious but rare side effect. You may need urgent medical attention or hospitalisation.

Treatment with Qvar® Autohaler® may affect the normal production of corticosteroids in the body, your doctor may take a blood sample from time to time to check on this.

Keep using your inhaler but see your doctor as soon as possible if you become unwell, particularly with any of the following:

  • abdominal pain
  • weakness
  • vomiting.

This is especially important if you have been exposed to other stress such as other illness, surgery or infection.

The following side effects may also occur in patients taking beclometasone dipropionate. If you experience any of these effects, keep using your inhaler but see your doctor if they last for a while or they are worrying you:

Common: may affect up to 1 in 10 people

  • hoarseness
  • difficulty in swallowing accompanied by earache and swollen glands, sore throat (pharyngitis)
  • a sore mouth or thrush (white spots in your mouth and throat). These are less likely if you rinse your mouth out with water after using your inhaler. If you get thrush, your doctor may recommend a medicine to treat you.
  • change in taste.

Uncommon: may affect up to 1 in 100 people

  • feeling sick
  • headache
  • tremor (shaking)
  • feeling dizzy or faint
  • difficulty in breathing, increase in wheezing, shortness of breath and cough (bronchospasm)
  • blurred vision.

Very rare: may affect up to 1 in 10,000 people

  • bone thinning
  • clouding of the lens of the eye (cataract) resulting in blurred vision
  • loss of vision due to abnormally high pressure in the eye may occur
  • rounded face (full moon) (Cushing’s syndrome).

The following may also occur, although the

frequency is not known: cannot be estimated from the available data

  • sleeping problems, depression or feeling worried, restless, nervous, over-excited or irritable. These effects are more likely to occur in children.

Children or adolescents who are using the inhaler for a prolonged period may grow more slowly. Your doctor may therefore wish to monitor the height of a child receiving prolonged treatment with Qvar® Autohaler®.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE QVAR® AUTOHALER®

  • Keep out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.
  • Do not store above 25°C.
  • Avoid storage in direct sunlight or heat. Protect from frost. You can use your inhaler at temperatures as low as -10°C.
  • Pressurised canister. may burst if heated. Do not smoke. Do not expose to temperatures higher than 50°C. Should not be punctured or burnt even if it seems empty.
  • Do not spray on flames or incandescent objects.
  • If your inhaler is not working properly or shows visible signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Qvar® Autohaler® contains:

The active ingredient is beclometasone dipropionate.

Each actuation delivers beclometasone dipropionate 100 micrograms into the mouthpiece.

The other ingredients are: Ethanol and Norflurane (Propellant HFA-134a). This medicine contains fluorinated greenhouse gases.

Each inhaler contains 13.13 g of norflurane (HFA-134a) corresponding to 0.01878 tonne CO2 equivalent (global warming potential GWP = 1430).

What Qvar® Autohaler® looks like and contents of the pack:

Qvar® is a grey and dark-red multidose autohaler® device enclosing a colourless solution in a pressurized canister and fitted with a metering valve and autohaler® actuator.

Each inhaler contains 200 actuations

Manufactured by 3M Health Care Limited, Derby Road, Loughborough, Leicestershire, LE11 5SF, UK.

Norton (Waterford) Limited, T/A Teva Pharmaceuticals Ireland, Unit 27/35 lDA Industrial Park, Cork Road, Waterford, Ireland.

Procured from within the EU and repackaged by the Product Licence Holder Beachcourse Ltd., Unit 2-3, Townsend Industrial Estate, Waxlow Road, London, NW10 7NU.

Revision date: 01.05.2026

PL 16378/0782 POM

Qvar® is a registered trademark of Teva Pharmaceuticals International GmbH.

Autohaler® is a registered trademark of Kindeva Drug Delivery L.P.

Blind or partially sighted?

Is this leaflet hard to see or read? Phone Beachcourse,

Tel: 020 8896 9054 for help. Ref. number: 0782/V4

For further information about asthma, contact Asthma UK, the independent UK charity working to conquer asthma:

Asthma UK, Summit House, 70 Wilson Street, London, EC2A 2DB Asthma Helpline: 0845 7 010203

(Open Monday to Friday, 9am to 5pm, calls charged at local rates.).

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 16378/0782

Last revision stated in the text: 1 May 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Qvar 100 Autohaler

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Beclometasone
Strength 100 microgram/dose
Pharmaceutical form Pressurised inhalation
How is it taken Inhalation
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03B Other drugs for obstructive airway diseases, inhalants
        1. R03BA Glucocorticoid inhalants for obstructive airway disease
          1. R03BA01 beclometasone
Marketing authorisation PLPI 16378/0782
Codes BNF 03020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.